>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
血清GRP78、PHB1在急性ST段抬高型心肌梗死患者病情评估、预后预测方面的临床价值研究
作者:聂明1  王淑1  刘娅菲1  陈芬2  刘建敏1 
单位:1. 安阳市人民医院 心脏重症监护室, 河南 安阳 455000;
2. 华中科技大学同济医学院附属协和医院 心内科, 湖北 武汉 430022
关键词:急性ST段抬高型心肌梗死 葡萄糖调节蛋白78 抗增殖蛋白1 预后 
分类号:R542.22
出版年·卷·期(页码):2023·42·第二期(180-187)
摘要:

目的:探究血清葡萄糖调节蛋白78(GRP78)和抗增殖蛋白1(PHB1)评估急性ST段抬高型心肌梗死患者病情及预后预测的临床价值。方法:选取2015年9月至2019年9月在安阳市人民医院接受治疗的188例急性ST段抬高型心肌梗死患者作为研究组,160例稳定型心绞痛患者作为对照组。使用全球急性冠状动脉事件注册(GRACE)风险评分将研究组患者分为低危组(79例)、中危组(72例)、高危组(37例)。采用酶联免疫吸附试验检测血清GRP78、PHB1的表达水平;Logistic回归分析急性ST段抬高型心肌梗死患者预后不良的影响因素;受试者工作特征(ROC)曲线分析血清GRP78、PHB1及二者联合对高危患者的评估效能及对患者预后不良的预测效能。结果:与对照组相比,研究组血清GRP78水平升高,且随患者病情危重程度加重而升高(P<0.05);血清PHB1水平降低,且随患者病情危重程度加重而降低(P<0.05)。血清GRP78、PHB1水平及二者联合评估高危患者的曲线下面积(AUC)分别为0.712、0.698、0.796,联合评估效能较优(P<0.05);与预后良好组比较,预后不良组患者血清GRP78水平升高(P<0.05),PHB1水平降低(P<0.05)。Logistic回归分析显示,吸烟史、左室射血分数(LVEF)、脑利钠肽(BNP)、低密度脂蛋白胆固醇(LDL-C)、肾小球滤过率估计值(eGFR)、GRP78、PHB1是急性ST段抬高型心肌梗死患者预后不良的影响因素(P<0.05)。ROC曲线分析显示,GRP78预测患者预后不良的AUC为0.738,敏感度为70.83%,特异度为76.72%;PHB1预测的AUC为0.758,敏感度为62.50%,特异度为81.03%;二者联合的AUC为0.837,敏感度为80.56%,特异度为74.14%。结论:血清GRP78、PHB1在急性ST段抬高型心肌梗死患者中异常表达,二者联合对评估急性ST段抬高型心肌梗死患者病情及预测患者不良预后具有较好效能。

Objective: To explore the clinical value of serum glucose-regulated protein 78(GRP78) and Prohibitin 1(PHB1) in evaluating the condition and prognosis of patients with acute ST-segment elevation myocardial infarction. Methods: 188 patients with acute ST-segment elevation myocardial infarction who were treated in Anyang People's Hospital from September 2015 to September 2019 were selected as the study group, and 160 patients with stable angina pectoris were selected as the control group. Using the Global Registry of Acute Coronary Events(GRACE) risk score, the patients in the study group were grouped into low-risk group(79 cases), intermediate-risk group(72 cases), and high-risk group(37 cases). The expression levels of serum GRP78 and PHB1 were detected by enzyme-linked immunosorbent assay; Logistic regression analysis was performed to analyze the influencing factors of poor prognosis in patients with acute ST-segment elevation myocardial infarction; receiver operating characteristic(ROC) curve analysis was performed to analyze the evaluation efficacy of serum GRP78, PHB1 and their combination for high-risk patients and the predictive efficacy for poor prognosis. Results: Compared with the control group, the expression level of serum GRP78 in the study group increased, and it increased with the severity of the patient's disease(P<0.05); the expression level of serum PHB1 decreased, and decreased with the severity of the patient's disease(P<0.05).The area under the curve(AUC) of serum GRP78, PHB1 and their combined assessment of high-risk patients was 0.712, 0.698, and 0.796, respectively, and the combined assessment efficacy was better(P<0.05); compared with the good prognosis group, the serum level of GRP78 in patients with poor prognosis increased(P<0.05), while the level of PHB1 decreased(P<0.05). Logistic regression analysis showed that smoking history, left ventricular ejection fraction(LVEF), brain natriuretic peptide(BNP),low density lippoproteincholesterol(LDL-C), estimated glomerular filtration rate(eGFR), GRP78 and PHB1 were the influencing factors of poor prognosis in patients with acute ST-segment elevation myocardial infarction(P<0.05). ROC curve analysis showed that the AUC of GRP78 for predicting poor prognosis was 0.738, with a sensitivity of70.83%, and a specificity of 76.72%; the AUC predicted by PHB1 was 0.758, with a sensitivity of 62.50%, and a specificity of 81.03%; the combined AUC of the two was 0.837, the sensitivity was 80.56%, and the specificity was 74.14%. Conclusion: Serum GRP78 and PHB1 are abnormally expressed in patients with acute ST-segment elevation myocardial infarction, and the combination of the two has high efficacy in evaluating the condition of patients with acute ST-segment elevation myocardial infarction and predicting the poor prognosis of patients.

参考文献:

[1] 王一茸,蔡伟聪,梁岭,等.2013—2018年深圳市急性心肌梗死发病情况及其变化趋势[J].中国慢性病预防与控制,2022,30(7):554-556.
[2] 胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.
[3] GULATI R,BEHFAR A,NARULA J,et al.Acute myocardial infarction in young individuals[J].Mayo Clin Proc,2020,95(1):136-156.
[4] DENG X,HE X,HUANG G,et al.The mechanism of rheinameliorating the survival rate of transplanted mesenchymal stem cells by improving myocardial microenvironment in acute myocardial infarction[J].J Biomater Tiss Eng,2021,11(4):684-689.
[5] TRAN-NGUYEN T K,CHANDRA D,YUAN K,et al.Glucose-regulated protein 78 autoantibodies are associated with carotid atherosclerosis in chronic obstructive pulmonary disease patients[J].Immunohorizons,2020,4(2):108-118.
[6] 宋欣,陈艳青,李静,等.内质网应激介导的细胞凋亡在牙周炎促血管钙化中的作用[J].精准医学杂志,2021,36(3):212-216.
[7] 徐逸洲,叶晨,唐磊,等.PHB1表达下调介导HMGB1促肺动脉内皮细胞损伤[J].中南大学学报(医学版),2020,45(9):1024-1034.
[8] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J].中华心血管病杂志,2019,47(10):766-783.
[9] 高晓津,杨进刚,吴超,等.TIMI风险评分与GRACE风险评分对中国ST段抬高型心肌梗死患者院内死亡率的预测价值[J].中国循环杂志,2018,33(6):529-534.
[10] TANRIVERDI Z,GUNGOREN F,TASCANOV M B,et al.Comparing the diagnostic value of the C-reactive protein to albumin ratio with other inflammatory markers in patients with stable angina pectoris[J].Angiology,2020,71(4):360-365.
[11] ZHANG Q,ZHAO D,XIE W,et al.Recent trends in hospitalization for acute myocardial infarction in Beijing:increasing overall burden and a transition from ST-segment elevation to non-ST-segment elevation myocardial infarction in a population-based study[J].Medicine(Baltimore),2016,95(5):1-9.
[12] YANG Q,GAO H,DONG R,et al.Sequential changes of endoplasmic reticulum stress and apoptosis in myocardial fibrosis of diabetes mellitus-induced rats[J].Mol Med Rep,2016,13(6):5037-5044.
[13] ZUO M Y,TANG T J,WANG X,et al.Atractylenolide III attenuates apoptosis in H9c2 cells by inhibiting endoplasmic reticulum stress through the GRP78/PERK/CHOP signaling pathway[J].Evid Based Complement Alternat Med,2022,2022(1):1-12.
[14] 钱徐萍,张学会,孙鲁宁,等.兰索拉唑诱导心肌细胞氧化应激损伤的机制研究[J].南京医科大学学报(自然科学版),2022,42(6):802-808.
[15] 于焱,高进辽,管博,等.载脂蛋白A-Ⅰ模拟肽通过抑制内质网应激改善肥胖合并心肌梗死大鼠的心功能[J].中华老年心脑血管病杂志,2022,24(6):634-638.
[16] 万朝辉,曾良,周辉.Bax抑制因子1过表达对急性心肌梗死大鼠心肌细胞凋亡的影响及其机制[J].吉林大学学报(医学版),2022,48(1):74-81.
[17] 刘晨,程国杰,甘榕榕.急性心肌梗死患者血清GRP78、mir-335表达与心功能关系[J].中国循证心血管医学杂志,2021,13(12):1483-1486.
[18] CHEN Y J,LI Y,GUO X,et al.Upregulation of IRF9 contributes to pulmonary artery smooth muscle cell proliferation during pulmonary arterial hypertension[J].Front Pharmacol,2021,12(1):1-16.
[19] 崔晓丽,沈泽,宋春垚,等.苦参总黄酮通过抗增殖蛋白抑制高糖诱导的心肌成纤维细胞增殖[J].药学学报,2019,54(11):1903-1908.
[20] 张杰,刘亮,周辉,等.上调抗增殖蛋白表达对TNF-α诱导的H9c2心肌细胞损伤的影响[J].郑州大学学报(医学版),2019,54(5):728-732.
[21] MATTOX T A,PSALTIS C,WEIHBRECHT K,et al.Prohibitin-1 is a dynamically regulated blood protein with cardioprotective effects in sepsis[J].J Am Heart Assoc,2021,10(14):1-37.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 464580 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626

苏ICP备09058364